Home/Filings/4/0001213900-25-123628
4//SEC Filing

HSU ERIC C 4

Accession 0001213900-25-123628

CIK 0001728328other

Filed

Dec 18, 7:00 PM ET

Accepted

Dec 19, 11:39 AM ET

Size

5.5 KB

Accession

0001213900-25-123628

Insider Transaction Report

Form 4
Period: 2025-12-19
HSU ERIC C
Sr VP, Pre-Clinical Res/Dev
Transactions
  • Award

    Employee Stock Option (Right to Buy)

    2025-12-19+13,00018,280 total
    Exercise: $1.29Exp: 2030-12-18Common shares (13,000 underlying)
Footnotes (1)
  • [F1]The options were granted on 12/19/2025 and will vest in equal installments monthly, in arrears, over 36 months (1/36 per month)

Documents

1 file

Issuer

InMed Pharmaceuticals Inc.

CIK 0001728328

Entity typeother

Related Parties

1
  • filerCIK 0001817867

Filing Metadata

Form type
4
Filed
Dec 18, 7:00 PM ET
Accepted
Dec 19, 11:39 AM ET
Size
5.5 KB